Matthew F. Wszolek, MD

Disclosure information not submitted.

Presentation(s):

• 020IC - Trimodality Therapy for Management of Muscle Invasive Bladder Cancer

  Friday, May 13, 2022
  4:00 PM – 6:00 PM